GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Demant AS (OTCPK:WILYY) » Definitions » ROE % Adjusted to Book Value

WILYY (Demant AS) ROE % Adjusted to Book Value : 4.17% (As of Dec. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Demant AS ROE % Adjusted to Book Value?

Demant AS's ROE % for the quarter that ended in Dec. 2024 was 24.67%. Demant AS's PB Ratio for the quarter that ended in Dec. 2024 was 5.92. Demant AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 was 4.17%.


Demant AS ROE % Adjusted to Book Value Historical Data

The historical data trend for Demant AS's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Demant AS ROE % Adjusted to Book Value Chart

Demant AS Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.32 3.07 4.80 2.90 4.20

Demant AS Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.86 1.90 3.79 3.71 4.17

Competitive Comparison of Demant AS's ROE % Adjusted to Book Value

For the Medical Devices subindustry, Demant AS's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Demant AS's ROE % Adjusted to Book Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Demant AS's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Demant AS's ROE % Adjusted to Book Value falls into.



Demant AS ROE % Adjusted to Book Value Calculation

Demant AS's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=24.85% / 5.92
=4.20%

Demant AS's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=24.67% / 5.92
=4.17%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Demant AS ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Demant AS's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Demant AS Business Description

Address
Kongebakken 9, Smorum, DNK, 2765
Demant AS is a Denmark-based company engaged in the healthcare industry. The company develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The Group focuses on four business areas: Hearing Devices, including such brands as Bernafon, Oticon, Frontrow, Phonic Ear and Sonic; Hearing Implants, including Oticon Medical; Diagnostic Instruments. The Company operates through more than 90 subsidiaries and associates all around the world. More than 80% of the company's sales come from North America and Europe.